Publicação
Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts
| Resumo: | Polyglutamine (PolyQ) diseases are a group of neurodegenerative disorders caused by the expansion of cytosine-adenine-guanine (CAG) trinucleotide repeats in the coding region of specific genes. This leads to the production of pathogenic proteins containing critically expanded tracts of glutamines. Although polyQ diseases are individually rare, the fact that these nine diseases are irreversibly progressive over 10 to 30 years, severely impairing and ultimately fatal, usually implicating the full-time patient support by a caregiver for long time periods, makes their economic and social impact quite significant. This has led several researchers worldwide to investigate the pathogenic mechanism(s) and therapeutic strategies for polyQ diseases. Although research in the field has grown notably in the last decades, we are still far from having an effective treatment to offer patients, and the decision of which compounds should be translated to the clinics may be very challenging. In this review, we provide a comprehensive and critical overview of the most recent drug discovery efforts in the field of polyQ diseases, including the most relevant findings emerging from two different types of approaches-hypothesis-based candidate molecule testing and hypothesis-free unbiased drug screenings. We hereby summarize and reflect on the preclinical studies as well as all the clinical trials performed to date, aiming to provide a useful framework for increasingly successful future drug discovery and development efforts. |
|---|---|
| Autores principais: | Esteves, Sofia |
| Outros Autores: | Silva, Sara Carina Duarte; Maciel, P. |
| Assunto: | polyglutamine diseases therapeutic strategies preclinical trials clinical trials |
| Ano: | 2017 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
Registos relacionados
article Neuroprotective effects of creatine in the CMVMJD135 mouse model of Spinocerebellar Ataxia type 3
por: Silva, Sara Carina Duarte
Publicado em: (2018)
por: Silva, Sara Carina Duarte
Publicado em: (2018)
article Targeting metabolic reprogramming in acute myeloid leukemia
por: Castro, Isabel
Publicado em: (2019)
por: Castro, Isabel
Publicado em: (2019)
article Huntington’s disease Clinical Trials Corner: January 2019
por: Rodrigues, Filipe Brogueira
Publicado em: (2019)
por: Rodrigues, Filipe Brogueira
Publicado em: (2019)
article Huntington’s disease Clinical Trials Corner: February 2018
por: Rodrigues, Filipe Brogueira
Publicado em: (2018)
por: Rodrigues, Filipe Brogueira
Publicado em: (2018)
article Expectations of benefit in a trial of a candidate disease-modifying treatment for Parkinson disease
por: Mestre, Tiago
Publicado em: (2021)
por: Mestre, Tiago
Publicado em: (2021)
article Fifteen years of clinical trials in Huntington’s disease: a very low clinical drug development success rate
por: Travessa, André
Publicado em: (2017)
por: Travessa, André
Publicado em: (2017)
article Clinical trials corner: September 2017
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
por: Rodrigues, Filipe Brogueira
Publicado em: (2017)
article Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis
por: Costa, Júlia
Publicado em: (2010)
por: Costa, Júlia
Publicado em: (2010)
article Cognitive impairment in fall-related studies in Parkinson’s disease
por: Domingos, Josefa M. M.
Publicado em: (2015)
por: Domingos, Josefa M. M.
Publicado em: (2015)
article Effects of bilateral discectomy and bilateral discopexy on black merino sheep rumination kinematics: TEMPOJIMS – phase 1 – pilot blinded, randomized preclinical study
por: Ângelo, David
Publicado em: (2018)
por: Ângelo, David
Publicado em: (2018)
school The scientific impact of commercial and non-commercial clinical trials in Portuguese lnstitutions
por: Andrade, Maria Pinheiro de Azevedo
Publicado em: (2019)
por: Andrade, Maria Pinheiro de Azevedo
Publicado em: (2019)
article A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease
por: Ferreira, Joaquim J
Publicado em: (2010)
por: Ferreira, Joaquim J
Publicado em: (2010)
article Ethyl-eicosapentaenoic acid treatment in Huntington's disease: a placebo-controlled clinical trial
por: Ferreira, Joaquim J
Publicado em: (2015)
por: Ferreira, Joaquim J
Publicado em: (2015)
article Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
por: Silva, Cláudia M.
Publicado em: (2019)
por: Silva, Cláudia M.
Publicado em: (2019)
article Old and new challenges in Parkinson's disease therapeutics
por: Pires, Ana O.
Publicado em: (2017)
por: Pires, Ana O.
Publicado em: (2017)
article Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities
por: Mainoli, Beatrice
Publicado em: (2021)
por: Mainoli, Beatrice
Publicado em: (2021)
article Preclinical assessment of mesenchymal-stem-cell-based therapies in spinocerebellar ataxia type 3
por: Correia, Joana Sofia Silva
Publicado em: (2021)
por: Correia, Joana Sofia Silva
Publicado em: (2021)
article Nocebo response in Parkinson's disease : a systematic review and meta-analysis
por: Leal Rato, Miguel
Publicado em: (2019)
por: Leal Rato, Miguel
Publicado em: (2019)
article The effect of prayer on patients’ health: systematic literature review
por: Simão, Talita Prado
Publicado em: (2016)
por: Simão, Talita Prado
Publicado em: (2016)
article Comparison of Huntington's Disease in Europe and North America
por: Orth, Michael
Publicado em: (2017)
por: Orth, Michael
Publicado em: (2017)
article ECCO Position Paper : harmonization of the approach to ulcerative colitis histopathology
por: Magro, Fernando
Publicado em: (2020)
por: Magro, Fernando
Publicado em: (2020)
school The Lessebo effect in Parkinson’s disease
por: Mestre, Tiago
Publicado em: (2020)
por: Mestre, Tiago
Publicado em: (2020)
school The efficacy of exercise interventions for people with Parkinson´s disease : a systematic review and meta-analysis
por: Rosário, Ana Filipa Lopes, 1986-
Publicado em: (2019)
por: Rosário, Ana Filipa Lopes, 1986-
Publicado em: (2019)
school Gestão dos processos inerentes à implementação e condução de ensaios clínicos de fase I
por: Fernandes, Carlos Filipe Teixeira
Publicado em: (2024)
por: Fernandes, Carlos Filipe Teixeira
Publicado em: (2024)
article Reclamação de eficácia terapêutica de um novo medicamento na ausência de dados provenientes de ensaios clínicos : problemas e limitações
por: Carneiro, António Vaz
Publicado em: (2006)
por: Carneiro, António Vaz
Publicado em: (2006)
article Novel Antiretroviral Therapeutic Strategies for HIV.
por: Cunha, Rita F.
Publicado em: (2021)
por: Cunha, Rita F.
Publicado em: (2021)
article Bioengineered temporomandibular joint disk implants : study protocol for a two-phase exploratory randomized preclinical pilot trial in 18 black merino sheep (TEMPOJIMS)
por: Ângelo, David
Publicado em: (2017)
por: Ângelo, David
Publicado em: (2017)
school Investigator-initiated clinical trials (IICTs) in Portugal: clinical investigator needs and support from clinical research infrastructure networks
por: Matias, Daniela Maria Sequeira
Publicado em: (2019)
por: Matias, Daniela Maria Sequeira
Publicado em: (2019)
article Investigação clínica da iniciativa do investigador em Portugal: identificação de problemas e propostas para melhoria
por: Ferreira, João Pedro
Publicado em: (2023)
por: Ferreira, João Pedro
Publicado em: (2023)
school Capacitação de centros de investigação clínica em estudos clínicos virtuais e remotos: elaboração de manual de boas práticas
por: Silveira, Maria Idalina Teixeira da
Publicado em: (2025)
por: Silveira, Maria Idalina Teixeira da
Publicado em: (2025)
article Adenosine and related drugs in brain diseases : present and future in clinical trials
por: Lopes, Luísa V.
Publicado em: (2011)
por: Lopes, Luísa V.
Publicado em: (2011)
school Gestão dos processos inerentes à implementação e condução de ensaios clínicos de fase I
por: Ganço, Marta Pinto Rodrigues Pereira
Publicado em: (2024)
por: Ganço, Marta Pinto Rodrigues Pereira
Publicado em: (2024)
school Gestão dos processos inerentes à implementação e condução de ensaios clínicos de fase I
por: Duarte, Ana Sofia Pinheiro
Publicado em: (2023)
por: Duarte, Ana Sofia Pinheiro
Publicado em: (2023)
article A generalização dos resultados de estudos clínicos através da análise de subgrupos
por: Costa, João
Publicado em: (2012)
por: Costa, João
Publicado em: (2012)
article Jacobson and Truax Method: evaluation of the clinical effectiveness of a home care program after prostatectomy
por: Mata, Luciana Regina Ferreira Pereira da
Publicado em: (2018)
por: Mata, Luciana Regina Ferreira Pereira da
Publicado em: (2018)
article Addressing challenges to enhance clinical research in Portugal: insights from the OncoT3 Expert Group Delphi Study
por: Resende, Catarina
Publicado em: (2024)
por: Resende, Catarina
Publicado em: (2024)
article Interpretation of chronic pain clinical trial outcomes : IMMPACT recommended considerations
por: Smith, Shannon M.
Publicado em: (2020)
por: Smith, Shannon M.
Publicado em: (2020)
article Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu’s arteritis
por: Quinn, Kaitlin A.
Publicado em: (2022)
por: Quinn, Kaitlin A.
Publicado em: (2022)
article The GO-DACT protocol : a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy
por: Vieira de Sousa, Elsa Cristina
Publicado em: (2018)
por: Vieira de Sousa, Elsa Cristina
Publicado em: (2018)
article Harmonizing quality improvement metrics across global trial networks to advance paediatric clinical trials delivery
por: Attar, Sabah
Publicado em: (2024)
por: Attar, Sabah
Publicado em: (2024)
Registos relacionados
-
article Neuroprotective effects of creatine in the CMVMJD135 mouse model of Spinocerebellar Ataxia type 3
por: Silva, Sara Carina Duarte
Publicado em: (2018) -
article Targeting metabolic reprogramming in acute myeloid leukemia
por: Castro, Isabel
Publicado em: (2019) -
article Huntington’s disease Clinical Trials Corner: January 2019
por: Rodrigues, Filipe Brogueira
Publicado em: (2019) -
article Huntington’s disease Clinical Trials Corner: February 2018
por: Rodrigues, Filipe Brogueira
Publicado em: (2018) -
article Expectations of benefit in a trial of a candidate disease-modifying treatment for Parkinson disease
por: Mestre, Tiago
Publicado em: (2021)